Novavax

YTD

ALL

Trade Novavax 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines.

CEO

John C.s Jacobs

CEOJohn C.s Jacobs

Employees

749

Employees749

Headquarters

Gaithersburg, Maryland

HeadquartersGaithersburg, Maryland

Founded

1987

Founded1987

Employees

749

Employees749

NVAX Key Statistics

Market cap

1.60B

Market cap1.60B

Price-Earnings ratio

-6.37

Price-Earnings ratio-6.37

Dividend yield

—

Dividend yield—

Average volume

7.76M

Average volume7.76M

High today

$9.95

High today$9.95

Low today

$9.62

Low today$9.62

Open price

$9.83

Open price$9.83

Volume

4.42M

Volume4.42M

52 Week high

$13.39

52 Week high$13.39

52 Week low

$6.20

52 Week low$6.20

Stock Snapshot

The current Novavax(NVAX) stock price is $9.79, with a market capitalization of 1.6B. The stock trades at a price-to-earnings (P/E) ratio of -6.37.

As of 2026-10-23, Novavax(NVAX) stock has fluctuated between $9.62 and $9.95. The current price stands at $9.79, placing the stock +1.8% above today's low and -1.6% off the high.

The Novavax(NVAX)'s current trading volume is 4.42M, compared to an average daily volume of 7.76M.

During the past year, Novavax(NVAX) stock moved between $6.20 at its lowest and $13.39 at its peak.

NVAX News

TipRanks 11h

Novavax Halts Omicron Booster Study, Raising Fresh Questions for NVAX Investors

Novavax (NVAX) announced an update on their ongoing clinical study. Novavax has updated a Phase 4 U.S. study called “A Phase 4, Randomized, Double-Blind, Place...

MarketWatch 2d

Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

...

Zacks 4d

Novavax Stock Declines While Market Improves: Some Information for Investors

Novavax (NVAX Quick QuoteNVAX - Free Report) closed at $10.82 in the latest trading session, marking a -3.91% move from the prior day. This move lagged th...

Analyst ratings

57%

of 7 ratings

Buy

57.1%

Hold

14.3%

Sell

28.6%

More NVAX News

Benzinga 5d

Novavax's Second-Largest Shareholder Sells $32.6 Million in Stock, Ends Activist Push

Novavax Inc. (NASDAQ:NVAX) major shareholder Shah Capital disclosed the sale of 2.87 million shares worth approximately $32.6 million and announced plans to shi...

Simply Wall St 6d

Is Novavax Expensive Or Cheap As Investors Reassess Vaccine Risk?

Novavax (NVAX) dropped 12.7% on 16 October as rising Treasury yields pulled money toward safer assets and away from growth-oriented healthcare stocks, leaving i...

People also own

Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.